|

KQB365 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Kumquat Biosciences Inc.1

Indications

  • CRC (Colorectal Cancer)1
  • Solid Tumor Malignancies1
  • KRAS G12S Mutation1
  • KRAS G12C Mutation1
  • Cancer1

Phoenix, Arizona1 trial

A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies

Mayo Clinic, Phoenix

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.